Developments Alligator reports encouraging OS for mitazalimab in metastatic pancreatic cancer Alligator Bioscience (STO:ATORX) has announced updated results from its Phase 2 OPTIMIZE-1 study evaluating mitazalimab in combination with chemotherapy as a first-line treatment for metastatic pancreatic cancer... February 26, 2025